# OnCo record naliricc (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/naliricc/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "naliricc", "NCT03043547" ;
  schema:name "NALIRICC (AIO)"@en ;
  schema:description "Adding a liposomal chemotherapy did not help in second-line bile duct cancer, contradicting an earlier Korean trial."@en ;
  schema:url <https://onco.cc/trials/naliricc/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00119-5/fulltext> ;
  onco:status "negative" ;
  onco:tag "failure", "lesson:replication" ;
  onco:phase "2" ;
  schema:startDate "2017-10-24" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/liposomal-irinotecan/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/leucovorin/> ;
  onco:companies <https://onco.cc/companies/aio/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-naliricc-lancet-gastroenterol-hepatol-2024/> .